Fundraising Fox

Mercator MedSystems

San Leandro, US · Delaware corporation · 2 known investors

Mercator MedSystems develops catheter-based Micro-Infusion technologies, including the Bullfrog Micro-Infusion Device, for the local delivery of pharmacologic and biologic agents to the peripheral vasculature. The medical device company runs clinical studies in deep vein thrombosis and below-the-knee peripheral arterial disease, with applications in cardiovascular treatment and denervation for hypertension.

Founders & leadership

KP
Kirk P. SewardinCo-founder, President and CEO
TR
Trent ReutimanNamed on SEC filing
SB
Stephen BakerNamed on SEC filing
CC
Charles CrockerNamed on SEC filing
DW
Doug WallNamed on SEC filing

Board

NSNed Scheetz
Ned ScheetzinBoard directorManaging Partner at Aphelion Capital

Investors · 2

Reported raises · per SEC filings

Form D private placements

$14.3M disclosed across 1 round · 2018

$14.3MraisedJun 2019 · 25 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Trent ReutimanExecutive Officer, Director
  • Stephen BakerExecutive Officer
  • Kirk SewardExecutive Officer
  • Charles CrockerDirector
  • Ned ScheetzDirector
  • Doug WallDirector
Offering amount
$15M
Amount sold
$14.3M
First sale
May 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 4

by search overlap

Companies competing with Mercator MedSystems for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 6 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2021$299.7K
National Institutes of Health (NIH)National Institutes of HealthPhase II2013$2M
National Institutes of Health (NIH)National Institutes of HealthPhase IISTTR2011$1.1M
National Institutes of Health (NIH)National Institutes of HealthPhase I2010$217.4K
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2009$218.1K
National Institutes of Health (NIH)National Institutes of HealthPhase I2007$194.2K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Mercator MedSystems do?
Mercator MedSystems develops catheter-based Micro-Infusion technologies, including the Bullfrog Micro-Infusion Device, for the local delivery of pharmacologic and biologic agents to the peripheral vasculature. The medical device company runs clinical studies in deep vein thrombosis and below-the-knee peripheral arterial disease, with applications in cardiovascular treatment and denervation for hypertension.
Who founded Mercator MedSystems?
Mercator MedSystems was founded by Kirk P. Seward.
Who are Mercator MedSystems's investors?
Mercator MedSystems's investors include Aphelion Capital, Medvest Capital.
How much funding has Mercator MedSystems raised?
Mercator MedSystems has disclosed $14.3M raised across 1 round.
Where is Mercator MedSystems headquartered?
Mercator MedSystems is headquartered in San Leandro, US.